Article Text
Statistics from Altmetric.com
Commentary on: OpenUrlCrossRefPubMedWeb of Science
Context
Pharmacological thromboprophylaxis has been proven effective for preventing venous thromboembolic events (VTE) in both surgical and acutely ill medical patients.1,–,3 Even though clinical guidelines recommend its use in both patient populations, thromboprophylaxis is more frequently used in surgical patients.4 This could be due to a lack of evidence for a mortality reduction associated with pharmacological thromboprophylaxis in acutely ill medical patients, even when data are pooled together in a meta-analysis.5
Methods
This study is an international multi-centre double-blind, placebo-controlled, randomised trial comparing enoxaparin 40 mg daily for 10±4 days compared with placebo …
Footnotes
-
Competing interests AS has received lecturing fees, travel support and consultancy fees from Actelion, Bayer, Bristol Myer Squibb, Boehringer Ingelheim, CSL Behring, Novartis, Octapharma, Pfizer and Sanofi Aventis.